Industry Supported Education

Meet the Embark® App – Designed to help Enbrel® (etanercept) patients throughout their treatment experience

Content Sponsored by Amgen Amgen has been a leader in the evolution of treatment options and patient experiences in rheumatology beginning with the approval of ENBREL for moderate to severe rheumatoid arthritis (RA) and psoriatic arthritis (PsA).1 ENBREL is a self-injectable biologic treatment for adult patients with moderately to severely active RA and PsA.1 ENBREL…